Jane Street
RDY icon

Jane Street’s Dr. Reddy's Laboratories RDY Stock Holding History

Jane Street’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,400
Closed -$137K – 10658
2025
Q1 		$137K Hold
10,400
– – ﹤0.01% 8665
2024
Q4 		$164K Buy
+10,400
New +$156K ﹤0.01% 8528

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street's RDY Position: Q1 2026 in Review

Jane Street sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 569,353 shares — an estimated $7.99M sold.

Jane Street first reported a position in RDY in Q2 2013 and held it in 36 quarters. The position peaked at $24.5M in Q4 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Jane Street reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 569,353 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $7.99M.
  • Jane Street first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 36 quarters.
  • Jane Street's Dr. Reddy's Laboratories position peaked at $24.5M in Q4 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.